Navigation Links
Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts
Date:8/1/2011

NEW YORK, Aug. 1, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts

http://www.reportlinker.com/p0581176/Dry-Powder-Inhalation-Devices-Drugs-Therapeutics-Markets-and-Forecasts .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Much of the interest in pulmonary delivery of systemic drug therapies is focused on chronic diseases and refractory conditions – aliments that require frequent drug administration for a protracted period of time. While several approaches for delivering active substances to, and systematically via, the lungs compete in this space, recent advances and investment in powder formulations, particle engineering, and device architecture have positioned dry powder inhalation (DPI) as a formidable challenger to more established pulmonary methods such as metered dose inhalers and nebulizers. While evolving DPI technology and combination therapeutic products continue to have a significant impact on the treatment of upper respiratory diseases and conditions, dry powder inhalers are making strides in applications requiring the systemic delivery of both small and large molecule and engineered macromolecules for the treatment of a range of pathologies.

Highlights

• Analyzes and evaluates Dry Powder Inhalers and competing inhaled drug delivery technologies and assesses the market potential for existing and probable future products

• Examines Dry Powder Inhaler design issues and evolving market factors

• Forecasts the impact of DPI technology and devices on drug delivery markets and projects probable future developments

• Provides forecasts of DPI combination product demand by indication and drug class to 2014

• Profiles Dry Powder Inhalation market participants, their technology, product development activity, and business strategies

Executive Summary

The Market Picture for Inhaled Therapeutics

Devices, Formulations and Market Evolution

Established Therapeutic Targets

Emerging Therapies

Demographics and Growth

Competing Technologies

Market Drivers

Risk Factors

Dry Powder Inhalation Technology

Dry Powder Formulations

Dry Powder Particle Technology & Powder Engineering

Dry Powder Formulations

Dry Powder Processing

Dry Powder Packaging

Emerging Formulations

Dry Powder Inhalers

DPI Device Characteristics

DPI Design Parameters

DPI Device Assessments

Acu-Breathe (Respirics)

Aerolizer Novartis)

AIR (Civitas/Alkermes)

Airmax (Teva)

Aspirair (Vectura)

Axahaler (S.M.B.)

Breezhaler (Novartis)

Clickhaler (Vectura)

Conix Dry (3M)

Cricket (Mannkind)

Cyclohaler (Teva)

Diskhaler (GlaxoSmithKline)

Diskus (GlaxoSmithKline)

Dreamboat (Mannkind)

Easyhaler (Orion)

EZ Aer (Aerovance)

Flexhaler (AstraZeneca)

Genuair (Almirall)

Gemini (GSK)

Handihaler Boehringer Ingelheim)

MicroDose (MicroDose Therapeutx)

Next DPI (Chiesi)

Novolizer (Meda)

Oximax (Mantecorp)

Podhaler (Novartis)

Pulmojet (sanofi-aventis)

Pulvinal (Chiesi)

Skyehaler (SKyepharma)

Solis (Sandoz/Novartis)

Taifun (Akela)

Taper Dry (3M)

Trivair (Trimel Bipharma)

Twincaps/Flowcaps (Hovione)

Twisthaler (Schering /Merck)

Turbuhaler (AstraZeneca)

Dry Powder Inhalation – Therapeutic Segment Analysis & Forecasts

Upper Respiratory Indications

Disease Segments

Therapeutic Landscape

Prescribing Trends and Growth Factors

Systemic Drug Delivery

Bioterror

Diabetes

Hereditary Diseases

Cystic Fibrosis

Infectious Diseases

Osteoporosis

Neurology

Pain Management

Market Factors

Device Design

Regulatory Issues

Patient Compliance

The Role of CMOs/CSOs

Healthcare Economics

Company Profiles

To order this report:

Drug Delivery Technology Industry: Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts

Drug Delivery Technology Business News

More  Company Profile, SWOT and Revenue Analysis!

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Data Show Aerovances Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients
3. ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients
4. New Powder Speeds Healing of Difficult Foot Wounds
5. Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lees Pharmaceuticals
6. FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
7. Hoviones TwinCaps(R) Dry-powder Inhaler Approved in Japan as Part of Inavir(R) Influenza Treatment
8. FDA Approves Pharmaxis ARIDOL™ (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
9. Reportlinker Adds Dry Powder Inhalation
10. Pharmaxis Launches ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
11. RSB Spine, LLC, Announces Distribution Agreement with Paradigm BioDevices, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):